Cochlear Limited, which creates implantable hearing devices, has taken a technological leap forward with a device that syncs up with various Apple products. The Nucleus 7 Sound Processor, which was ...

LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

Using visual support technology powered by TechSee, Cochlear has been able to bolster their customer experience by focusing on the needs of recipients through the use of Augmented Reality. NEW YORK, ...

In a report released on February 14, David Low from J.P. Morgan upgraded Cochlear Limited (CHEOF – Research Report) to a Buy, with a price target of A$311.00. The company’s shares closed last Friday ...

In a report released today, Sean Laaman from Morgan Stanley maintained a Hold rating on Cochlear Limited (CHEOF – Research Report), with a price target of A$240.00. The company’s shares closed ...

LONE TREE, Colo., June 2, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announces today the commercial release of the new Cochlear™ Baha® 7 ...

LONE TREE, Colo., Feb. 25, 2025 /PRNewswire/ -- In celebration of International Cochlear Implant Day, Cochlear North America is thrilled to announce the winners of 2025 annual Cochlear Academic ...

Cochlear Limited ((CHEOF)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Study Overview: Cochlear Limited is ...